StockData
Nuvation Bio Inc. logo

Nuvation Bio Inc. (NUVB) stock

NUVBNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30107% above fair value
$3.90+0.06 (+1.56%)

Close on Nov 17, 2026Market cap $1.37BP/E –Yield –

Nuvation Bio price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Nuvation Bio's price to book ratio was 5.9× on Nov 11, 2026, against 8.3× a year earlier. Over the last 5 years it ranged from 0.3× to 9.3×, with a median of 1.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20265.9×−3.4
2025Dec 31, 20259.3×+7.5
2024Dec 31, 20241.8×+1.2
2023Dec 29, 20230.5×−0.1
2022Dec 30, 20220.6×−1.8
2021Dec 31, 20212.4×–

More Nuvation Bio figures

See a number that looks wrong?